EYEGATE PHARMACEUTICALS INC (EYEG) has 38 open-market insider trades by 12 insiders since 2015. The most active filer is Steven Boyd, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Steven Boyd | Dir10% Owner | — | 10 | $46.6M | 2021-07-29 |
| Armistice Capital, LLC via Steven Boyd | 10% Owner | — | 6 | $8.7M | 2021-08-02 |
| Armistice Capital Master Fund Ltd. | 10% Owner | — | 3 | $2.5M | 2018-05-29 |
| (innoven Partenaires S.a.) Ipsa | 10% | — | 1 | $2.2M | 2015-02-19 |
| Ventech Capital II | 10% Owner | — | 5 | $899K | 2017-03-13 |
| Morton Goldberg | Dir | — | 5 | $169K | 2019-12-06 |
| Stephen From | Chairman | — | 3 | $65K | 2021-11-02 |
| Paul G. Chaney | Dir | — | 1 | $50K | 2018-07-10 |
| Sarah Romano | CFO | — | 2 | $19K | 2021-11-02 |
| Brenda Mann | VP | — | 1 | $9K | 2021-11-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Armistice Capital, LLC | 10% Owner | Sell | $830K | 2021-07-30 |
| Steven Boyd | Director & 10% Owner | Sell | $27.9M | 2021-07-27 |
| Steven Boyd | Director & 10% Owner | Buy | $16.0M | 2021-01-06 |
| Armistice Capital, LLC | Director & 10% Owner | Buy | $140K | 2020-02-06 |
| Morton Goldberg | Director | Sell | $14K | 2019-12-06 |
| Morton Goldberg | Director | Sell | $9K |
Companies that share insiders with EYEG, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-11-12 |
| Steven Boyd | Director & 10% Owner | Buy | $1.9M | 2019-09-29 |
| Barbara Wirostko | Chief Medical Officer | Sell | $5K | 2019-07-11 |
| Sarah Romano | CFO | Sell | $9K | 2019-07-11 |
| Michael P. Manzo | VP of Engineering | Sell | $5K | 2019-07-11 |
| Stephen From | President | Sell | $30K | 2019-07-11 |
| Brenda Mann | VP | Sell | $9K | 2019-07-11 |
| Steven Boyd | Director & 10% Owner | Buy | $268K | 2019-03-27 |
| Steven Boyd | Director & 10% | Buy | $40K | 2018-12-10 |
| Steven Boyd | Director & 10% Owner | Buy | $84K | 2018-11-16 |